Anxiety Without a Cause: Understanding Symptoms, Root Causes, and Long-Term Consequences

By Guillermo Salinas Araya · June 1, 2026 · Educational material

The concept of chronic low-grade neuroinflammation, first described in neurology journals in 2008, explains why so many adults experience unexplained fatigue, brain fog, and insomnia without finding a clear organic cause on conventional lab tests.

Medical Definition of Anxiety Without a Cause

The term anxiety without a cause refers to a clinical condition with established diagnostic criteria in recent medical literature. Understanding it requires distinguishing between the entity itself, its presentations, and its underlying mechanisms. Updated international guidelines have reformulated several of these criteria over the past decade, expanding what conventional clinical practice has not yet incorporated.¹

Pathophysiology: How It Develops

The pathophysiological cascade of anxiety without a cause involves multiple parallel mechanisms that feed into each other. The single-cause hypothesis has been replaced by integrative models that recognize the interaction of several axes:²

• Endocrine-metabolic axis: altered insulin sensitivity and hepatic lipogenesis.
• Inflammatory axis: low-grade pro-inflammatory cytokines (TNF-α, IL-6, elevated high-sensitivity CRP).
• Mitochondrial axis: respiratory chain dysfunction and increased reactive oxygen species.
• Intestinal axis: altered microbiome, increased intestinal permeability, endotoxin translocation.
• Neuroendocrine axis: dysregulation of the hypothalamic-pituitary-adrenal axis with chronically elevated cortisol.

The simultaneous accumulation of these five impacts is what distinguishes the pathological state from the physiological state of compensatory tolerance. Patients can spend years with one or two active axes without clinical manifestation—until convergence overwhelms adaptive mechanisms.

Clinical Signs and Symptoms

Clinical presentation is heterogeneous. In early phases, most patients are paucisymptomatic or asymptomatic.³ Signs and symptoms that guide diagnosis include:

• Unexplained fatigue, especially postprandial
• Progressive increase in waist circumference
• Skin changes (spots, papules, hair alterations)
• Sleep-wake cycle disturbances
• Neurocognitive symptoms: brain fog, difficulty concentrating, irritability
• Nonspecific laboratory findings: mildly elevated CRP, mild hepatic or lipid abnormalities frequently categorized as "high normal"
• Subtle ultrasound findings requiring targeted examination

Long-Term Consequences if Left Unaddressed

The natural history of anxiety without a cause without adequate intervention involves silent but predictable progression:⁴

• Increased cardiovascular risk independent of cholesterol
• Accelerated development of type 2 diabetes in patients with prediabetes
• Progression toward structural organ damage within 5 to 15 years
• Increased cancer risk documented in longitudinal cohorts
• Progressive functional decline that reduces quality of life and healthy life expectancy

The therapeutic window of opportunity—the period during which the condition is completely reversible—is proportional to exposure time and the number of pathophysiological axes involved. Every year lost without comprehensive intervention narrows that window.

Can It Be Reversed?

Contemporary clinical evidence is conclusive: in pre-irreversible stages, reversal is possible. But it requires addressing all five pathophysiological axes simultaneously, not sequentially or in isolation. This is where conventional approaches fail: they intervene on a single axis and leave the other four active.

The educational protocol we designed—The Salinas Method—comprises 8 sequential phases. Each phase addresses a distinct mechanism in the cascade. Phases 1 and 2 prepare the cellular terrain and correct the microbiome. Phases 3 through 6 dismantle low-grade inflammation, mitochondrial dysfunction, insulin resistance, and cortisol axis disruption. Phases 7 and 8 consolidate the change and prevent relapse.

It's not a diet. It's not isolated fasting. It's not a supplement. It's a guided educational protocol, step by step, based on the most recent clinical evidence and designed so patients understand the why behind each action.

References

1. Theoharides TC, et al. Brain 'fog,' inflammation and obesity. Front Neurosci. 2015. PubMed
2. Buysse DJ. Insomnia. JAMA. 2013. PubMed
3. Bhat A, et al. Inflammation in chronic fatigue syndrome. Brain Behav Immun. 2020. PubMed
4. Riemann D, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017. PubMed

100% educational material. Does not replace personal medical consultation. References verifiable on PubMed.